Skip to main content

Oracle Application Testing Suite EUVDEUVD-2026-105960

| CVE-2026-101549 HIGH
2026-10-20 secalert_us@oracle.com GHSA-4cvx-qj9m-q3cc
7.8
CVSS 3.1 · NVD
View

Attack ChainAIDerived

Hypothetical attack flow derived from CVE metadata – not a confirmed exploit chain

  1. Access
    Obtain low-privileged logon to ATS host
  2. Delivery
    Interact with OpenScript component
  3. Exploit
    Exploit flaw (AC:L, no UI)
  4. Execution
    Execute with elevated control
  5. Impact
    Full takeover of Oracle Application Testing Suite

Vulnerability Assessment

Exploitation Conditions

Exploitation requires the attacker to already hold authenticated local logon access (PR:L, AV:L) to the infrastructure host where Oracle Application Testing Suite 13.3.0.1 executes, and the flaw resides specifically in the OpenScript component. There is no remote and no network-exploitable path and no user interaction is needed once the attacker has that local account. Limiting factors that reduce real-world risk: the mandatory local-account prerequisite, confinement to the single affected version (13.3.0.1), and the absence of any public exploit; the practical exposure is largely bounded to multi-user or shared test servers where untrusted or lower-tier accounts can log on.

Impact

The CVSS 3.1 vector (AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H, base 7.8 HIGH) describes a locally-exploitable flaw: the attacker must already have authenticated logon access (PR:L) to the host where Oracle Application Testing Suite runs, but once present, exploitation is low-complexity (AC:L), requires no user interaction, and yields full confidentiality, integrity, and availability compromise (complete product takeover). The local attack vector is the dominant risk-limiting factor - this is not a remotely reachable pre-auth bug, so mass internet-scanning exploitation is implausible. No EPSS score was provided in the input, so exploitation probability cannot be quantified. The CVE is NOT in CISA KEV and no public POC is referenced, so there is no evidence of active or available exploitation. SSVC framing: exploitation=none observed, automatable=no (local access prerequisite), technical impact=total. Net: a genuinely high-impact local privilege/takeover issue worth patching on exposed multi-user test infrastructure, but the local-access requirement makes it a lower operational priority than a comparably-scored network-exploitable flaw. Note a tagging inconsistency: the input tag 'Information Disclosure' understates the impact, which the vector shows as full C/I/A takeover, not mere disclosure - treat the vector as authoritative.

Exploit ScenarioDerived

A low-privileged user (or an attacker who has already gained a foothold) with local logon access to the server hosting Oracle Application Testing Suite abuses a flaw in the OpenScript component to escalate to full control of the Testing Suite installation. No public exploit code is identified at time of analysis, and the local-access and authentication prerequisites mean the attacker must first obtain an account on the host.

This Week Schedule remediation this week. Why: HIGH severity (CVSS 7.0-8.9).
No patch listed yet 0.2% exploitation probability (EPSS)

Get an e-mail when this CVE is exploited, patched or re-scored. Free account.

Alert me

AnalysisAIv1 – Oct 21, 2026

Local takeover of Oracle Application Testing Suite 13.3.0.1 through its OpenScript component: any user who can log on to the host running the suite can leverage the flaw to gain full control of the product, with high confidentiality, integrity and availability impact (CVSS 3.1 base 7.8, AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H). The prerequisite is meaningful - the attacker must already hold an authenticated local account on the ATS infrastructure host - but once that condition is met, exploitation is low-complexity and requires no user interaction. There is no remote or network-exploitable path, no public exploit identified at time of analysis, and exposure is effectively bounded to shared or multi-user test servers where lower-tier or untrusted accounts are permitted to log on.

RemediationAI

Apply the Oracle Critical Patch Update for October 2026 (https://www.oracle.com/security-alerts/cpuoct2026.html), which is the vendor's remediation vehicle for this issue; the exact patched build number is not stated in the available data, so verify the fixed 13.3.0.1 build level against that advisory before rollout and treat any pre-CPU installation as unpatched. Where patching must be staged, reduce the attack surface that the PR:L/AV:L prerequisite depends on: restrict interactive logon rights on ATS hosts to a named group of test administrators and remove lower-tier, contractor and service accounts from local logon and Remote Desktop groups (side effect: legitimate shared-server test workflows and any automated build agents using those accounts will break until re-provisioned), and audit which accounts can invoke OpenScript or write to its script and plugin directories, since only accounts that can already log on locally can reach the flaw. Isolate ATS test servers on a segmented management VLAN that accepts no inbound sessions from general user subnets (side effect: developers lose direct desktop access and must go through a jump host). Log and alert on local logon events and OpenScript process launches by non-administrative accounts, and consider removing or renaming the OpenScript component on hosts where scripting is not actively used - noting that doing so disables test automation functionality on that host.

Affected VersionsENISA

Oracle Application Testing Suite 13.3.0.1

Affected Packages

euvd oracle_application_testing_suite no fix

Source: OSV (Open Source Vulnerabilities)

Affects your stack

Affects 1 package in euvd

Checking this CVE against your own stacks and servers is part of the Basic plan and up.

Technical ContextAI · show details

The flaw sits in OpenScript, the script authoring and execution engine shipped with Oracle Application Testing Suite, which runs scripts with the privileges of the invoking account on the ATS host. The CVSS vector is strictly local (AV:L) with a low-privileged authenticated requirement (PR:L) and no user interaction (UI:N), meaning the access-control or isolation boundary between a routine logged-on account and the OpenScript/ATS execution context is insufficient - the assessed impact is a full-scope (S:U) compromise of confidentiality, integrity and availability within the same security authority. No CWE identifier and no CPE strings were supplied with the available data, so the precise root-cause class (for example an insecure local execution path or missing privilege boundary in the component) cannot be confirmed from the inputs; the root cause should be treated as a local privilege/trust boundary weakness in OpenScript rather than a memory-safety or remote-input issue. Only version 13.3.0.1 is listed as affected by both Oracle and ENISA EUVD, which points to a defect introduced or present in that specific release line.

Know when the next one hits your stack

  • Watch products and get an email when something new is published
  • Check this CVE against your own stack and servers
  • Exploit and PoC references, threat intelligence from 22 sources

No credit card · 7-day full trial

Severity by source

NVD PRIMARY 7.8 HIGH
AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
vuln.today AI 7.8 HIGH

Vendor states local logon with low privileges and no interaction (AV:L/PR:L/UI:N), low complexity, and the result is full product takeover, so C/I/A all High.

3.1 AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
4.0 AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N

Primary rating from NVD.

CVSS VectorNVD

Attack Vector
Local
Attack Complexity
Low
Privileges Required
Low
User Interaction
None
Scope
Unchanged
Confidentiality
High
Integrity
High
Availability
High

DescriptionNVD

Vulnerability in Oracle Application Testing Suite (component: OpenScript). The supported version that is affected is 13.3.0.1. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Oracle Application Testing Suite executes to compromise Oracle Application Testing Suite. Successful attacks of this vulnerability can result in takeover of Oracle Application Testing Suite. CVSS 3.1 Base Score 7.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

Executive ViewAI

Why It Matters

Oracle Application Testing Suite 13.3.0.1 (OpenScript component) contains a high-severity local privilege escalation flaw that lets any user with an existing account on the ATS host seize full control of the product, with high impact to confidentiality, integrity and availability. Because exploitation requires a pre-existing local login and there is no network path, exposure is concentrated in shared or multi-user QA/test servers where broad or lower-trusted accounts are permitted - leadership should care primarily about who currently holds logon rights to those hosts and what test systems and data they can reach once escalated.

Business Impact: Medium
Compensating Controls

No vendor-released patch identified at time of analysis. Restrict interactive logon on ATS 13.3.0.1 hosts to a minimal, named administrator group; remove or disable unnecessary and lower-trusted local accounts on shared multi-user test servers; enforce least privilege and separate administrative accounts from day-to-day test accounts; network-segment ATS infrastructure away from production systems; enable and monitor local account, privilege-escalation, and OpenScript activity logging; and maintain an inventory of affected hosts with a defined review cadence until an Oracle fix is available.

Threat Intelligence Overview

EPSS Score
0.2%
Top 96% exploitable
Prevalence
Low
niche Oracle QA/test automation tool, limited enterprise deployment footprint
Data Quality
4 sources
Confidence: Medium

How this decision was reached

The engine reads each signal below and applies a fixed list of rules from top to bottom. The first rule that matches sets the recommended action – like a statement, every line is shown.

SignalValue
Severity HIGH
CISA KEV No
Public POC No
EPSS 0.2%
Patch available No
Active threat No
Deciding rule
HIGH severity (CVSS 7.0-8.9)
What every action level means
Emergency Immediate action required. Criteria: CRITICAL + in CISA KEV (actively exploited) without patch, OR CRITICAL + EPSS > 30% without patch, OR CRITICAL + active threat signals without patch.
Act Now Prioritize within 24-48h. Criteria: in KEV with patch available, OR CRITICAL + public POC, OR HIGH + EPSS > 10%, OR CRITICAL + active threat, OR any CRITICAL severity.
This Week Schedule remediation this week. Criteria: HIGH severity (CVSS 7.0-8.9). Patch within normal change window.
This Month Plan within 30 days. Criteria: MEDIUM severity (CVSS 4.0-6.9), lower exploitation probability. Include in regular patch cycle.
Monitor Track and reassess. Criteria: LOW severity (CVSS 0.1-3.9), minimal exploitation risk. No immediate action needed.

SSVC AssessmentENISA

SSVC Decision· derived
Defer
Exploitation· derived
None
System Exposure· derived
Small
Automatable· derived
No
Human Impact
Medium

Priority Score

39
Low Medium High Critical
KEV: 0
EPSS: 0
CVSS: +39
PoC: 0
Weaponized: 0
Threat intel: 0
Gov advisory: 0

Attack Technique

Information disclosure occurs when an application unintentionally exposes sensitive data that aids attackers in reconnaissance or directly compromises security.

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy